Synthego is a genome engineering company dedicated to accelerating life science research and development to improve human health. By leveraging advanced technologies such as machine learning, automation, and gene editing, Synthego creates integrated platforms that encompass proprietary hardware, software, bioinformatics, and molecular biology. This comprehensive approach supports a wide range of applications, from basic research to clinical trials, offering both academic and commercial researchers unprecedented access to state-of-the-art genome engineering tools. Committed to innovation and collaboration, Synthego aims to empower scientists in their quest to develop the next generation of therapeutics and diagnostics, thereby making a significant impact on the future of medicine.